-
GS-441524
- names:
CID 44468216
- CAS号:
1191237-69-0
MDL Number: - MF(分子式): C12H13N5O4 MW(分子量): 291.263
- EINECS: Reaxys Number:
- Pubchem ID:44468216 Brand:BIOFOUNT
| 货品编码 | 规格 | 纯度 | 价格 (¥) | 现价(¥) | 特价(¥) | 库存描述 | 数量 | 总计 (¥) |
|---|
| 中文别名 | GS441524;瑞德西韦中间体;瑞德西韦杂质;GS-441524;EVO-984;EVO 984;gs441524瑞德西韦 |
| 英文别名 | GS-441524;(2R,3S,5R)-2-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxyméthyl)tétrahydro-2-furanecarbonitrile (non-preferred name)GS 441524;(2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile |
| CAS号 | 1191237-69-0 |
| Inchi | InChI=1S/C12H13N5O4/c13-4-12(10(20)9(19)7(3-18)21-12)8-2-1-6-11(14)15-5-16-17(6)8/h1-2,5,7,9-10,18-20H,3H2,(H2,14,15,16)/t7-,9-,10-,12+/m1/s1 |
| InchiKey | BRDWIEOJOWJCLU-LTGWCKQJSA-N |
| 分子式 Formula | C12H13N5O4 |
| 分子量 Molecular Weight | 291.263 |
| 溶解度Solubility | |
| 性状 | white power |
| 储藏条件 Storage conditions | Store at room temp;常温阴凉干燥处存储 |
GS-441524与瑞德西韦相比较,研究发现GS-441524不能很好地进入细胞。
GS-441524 has been found to transport poorly into cells compared to remdesivir.
GS-441524 is phosphorylated 3 times to form the active nucleoside triphosphate。
GS-441524被三磷酸活化后,可以形成“GS-441524三磷酸腺”(GS-443902|1355149-45-9),目前已经被应用于抑制新型冠状病毒的研究中,实验证明GS-443902可以终止新型冠状病毒的复制。
GS-441524合成制备的工艺说明:
制备方法:将1.50g(I-1)的核苷化合物加入圆底烧瓶中,将200mL四氢呋喃和2.47g(F)的活性磷酸酯在冰浴中冷却至0℃ 在搅拌下缓慢加入10mL的叔丁基氯化镁溶液(1.0M四氢呋喃溶液)。滴加完成后,将温度升至40℃,并使反应进行2小时。 反应后,将反应溶液在减压下浓缩,将浓缩物加入到200mL二氯甲烷中,并用50mL饱和氯化钠溶液洗涤两次。有机相用无水硫酸钠干燥并在减压下浓缩。 通过硅胶柱色谱法使用乙酸乙酯/石油醚= 1/1的混合物作为洗脱剂分离浓缩的残余物,获得1.58g(I-6)的化合物,并且计算的产率为52%。
步骤1:(2R,3R,4S,5R)-2-(4-氨基吡咯并[1,2-f] [1,2,4]三嗪-7-基)-3,4-二羟基-5-( 羟甲基)四氢呋喃-2-腈与叔丁基氯化镁在四氢呋喃中于20℃加热; 持续0.5h; 冰冷却;
步骤2:四氢呋喃中于20℃的环戊基((全氟苯氧基)(苯氧基)磷酰基)-L-丙氨酸盐; 持续24小时。
GS-441524 has been found to transport poorly into cells compared to remdesivir.
GS-441524 is phosphorylated 3 times to form the active nucleoside triphosphate。
GS-441524被三磷酸活化后,可以形成“GS-441524三磷酸腺”(GS-443902|1355149-45-9),目前已经被应用于抑制新型冠状病毒的研究中,实验证明GS-443902可以终止新型冠状病毒的复制。
GS-441524合成制备的工艺说明:
制备方法:将1.50g(I-1)的核苷化合物加入圆底烧瓶中,将200mL四氢呋喃和2.47g(F)的活性磷酸酯在冰浴中冷却至0℃ 在搅拌下缓慢加入10mL的叔丁基氯化镁溶液(1.0M四氢呋喃溶液)。滴加完成后,将温度升至40℃,并使反应进行2小时。 反应后,将反应溶液在减压下浓缩,将浓缩物加入到200mL二氯甲烷中,并用50mL饱和氯化钠溶液洗涤两次。有机相用无水硫酸钠干燥并在减压下浓缩。 通过硅胶柱色谱法使用乙酸乙酯/石油醚= 1/1的混合物作为洗脱剂分离浓缩的残余物,获得1.58g(I-6)的化合物,并且计算的产率为52%。
步骤1:(2R,3R,4S,5R)-2-(4-氨基吡咯并[1,2-f] [1,2,4]三嗪-7-基)-3,4-二羟基-5-( 羟甲基)四氢呋喃-2-腈与叔丁基氯化镁在四氢呋喃中于20℃加热; 持续0.5h; 冰冷却;
步骤2:四氢呋喃中于20℃的环戊基((全氟苯氧基)(苯氧基)磷酰基)-L-丙氨酸盐; 持续24小时。
| Bioactivity|In vitro: Efficacy|Quantitative Results |
| pX | Parameter | Value (qual) | Value (quant) | Unit | Cell | Dose | Effect |
| 7.28 | inhibition rate | 100 | CRFK cell line | 1 μM | Anticytopathic | ||
| 6.74 | EC50(viral titre reduction) | 0.18 | μM | airway epithelium cell | antiviral agent | ||
| 6.66 | IC50 | 0.22 | µM | HAEC cell line | antiviral agent | ||
| 6.32 | EC50(Virus-induced cytopathic effect) | = | 0.48 | µM | HEp-2 cell line | antiviral agent | |
| 6 | IC50 | 1000 | nM | HeLa cell line | antifungal agent | ||
| 5.77 | EC50(Virus replication) | = | 1.71 | μM | Vero cell line | antiviral agent | |
| 5.28 | IC90 | > | 47 | μM | Vero cell line | 0.047 – 47 μM | Anticytopathic |
| 4.55 | EC50(Virus replication) | = | 27.9 | μM | MDCK cell line | antiviral agent | |
| 1 | CC50 (cytotoxic concentration)(Cell growth) | > | 89 | μM | Huh-7 cell line | Cytotoxic |
| 产品说明 | GS-441524(GS 441524)是一种腺苷核苷酸类似物抗病毒药,类似于瑞德西韦,GS-441524也是合成瑞德西韦的中间体。 |
| Introduction | GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. |
| Application1 | GS-441524是合成潜在冠状病毒药物瑞德细韦的中间体。 |
| Application2 | GS-441524是瑞德西韦的杂质。 |
| Application3 |
GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir. GS-441524 continues to be studied in the treatment of Feline Infectious Peritonitis Virus, a coronavirus that only infects cats.
| 警示图 | |
| 危险性 | |
| 危险性警示 | Not available |
| 安全声明 | H226,H315,H319,H335 |
| 安全防护 | P264, P280, P302+P352, P305+P351+P338, P321, P332+P313, P337+P313, and P362 |
| 备注 |
| GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir. GS |
| GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. |
GS441524的参考文献:
GS-441524 is an adenosine nucleotide analog antiviral, similar to remdesivir. This molecule was patented in 2009. In vitro studies of GS-441524 have determined it has a higher EC50 than remdesivir. GS-441524 continues to be studied in the treatment of Feline Infectious Peritonitis Virus, a coronavirus that only infects cats。
Murphy BG, Perron M, Murakami E, Bauer K, Park Y, Eckstrand C, Liepnieks M, Pedersen NC: The nucleoside analog GS-441524 strongly inhibits feline infectious peritonitis (FIP) virus in tissue culture and experimental cat infection studies. Vet Microbiol. 2018 Jun;219:226-233. doi: 10.1016/j.vetmic.2018.04.026. Epub 2018 Apr 22. [PMID:29778200]
Amirian ES, Levy JK: Current knowledge about the antivirals remdesivir (GS-5734) and GS-441524 as therapeutic options for coronaviruses. One Health. 2020 Mar 27;9:100128. doi: 10.1016/j.onehlt.2020.100128. eCollection 2020 Jun. [PMID:32258351]
Lo MK, Jordan R, Arvey A, Sudhamsu J, Shrivastava-Ranjan P, Hotard AL, Flint M, McMullan LK, Siegel D, Clarke MO, Mackman RL, Hui HC, Perron M, Ray AS, Cihlar T, Nichol ST, Spiropoulou CF: GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses. Sci Rep. 2017 Mar 6;7:43395. doi: 10.1038/srep43395. [PMID:28262699]
de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H: Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci U S A. 2020 Feb 13. pii: 1922083117. doi: 10.1073/pnas.1922083117. [PMID:32054787]
对不起,暂无产品评价!
MSDS
SDS 1.0 中文
展开
SDS 1.0 英文
展开
- 相关产品
-
< >
- 推荐产品
-
< >
- 最新产品
-
< >
新闻
抱歉,暂无数据!


购物车 


